| A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs F Barbosa Jr, JE Tanus-Santos, RF Gerlach, PJ Parsons Environmental health perspectives 113 (12), 1669-1674, 2005 | 928 | 2005 |
| Circulating interleukin‐6 and high‐sensitivity C‐reactive protein decrease after periodontal therapy in otherwise healthy subjects AM Marcaccini, CA Meschiari, CA Sorgi, MCP Saraiva, AM de Souza, ... Journal of periodontology 80 (4), 594-602, 2009 | 253 | 2009 |
| Protective effect of Calendula officinalis extract against UVB-induced oxidative stress in skin: Evaluation of reduced glutathione levels and matrix metalloproteinase secretion YM Fonseca, CD Catini, FTMC Vicentini, A Nomizo, RF Gerlach, ... Journal of ethnopharmacology 127 (3), 596-601, 2010 | 235 | 2010 |
| Gingival crevicular fluid levels of MMP‐8, MMP‐9, TIMP‐2, and MPO decrease after periodontal therapy AM Marcaccini, CA Meschiari, LR Zuardi, TS De Sousa, M Taba Jr, ... Journal of clinical periodontology 37 (2), 180-190, 2010 | 229 | 2010 |
| Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats MM Castro, E Rizzi, L Figueiredo-Lopes, K Fernandes, LM Bendhack, ... Atherosclerosis 198 (2), 320-331, 2008 | 217 | 2008 |
| Sex determination of human remains from peptides in tooth enamel NA Stewart, RF Gerlach, RL Gowland, KJ Gron, J Montgomery Proceedings of the National Academy of Sciences 114 (52), 13649-13654, 2017 | 198 | 2017 |
| Inhibition of human gingival gelatinases (MMP-2 and MMP-9) by metal salts AP De Souza, RF Gerlach, SRP Line Dental Materials 16 (2), 103-108, 2000 | 183 | 2000 |
| Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension MM Castro, E Rizzi, GJ Rodrigues, CS Ceron, LM Bendhack, RF Gerlach, ... Free Radical Biology and Medicine 46 (9), 1298-1307, 2009 | 169 | 2009 |
| As organizações sociais de saúde como forma de gestão público/privado NB Barbosa, PEM Elias Ciência & Saúde Coletiva 15, 2483-2495, 2010 | 168 | 2010 |
| Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and … ACT Palei, VC Sandrim, RC Cavalli, JE Tanus-Santos Clinical Biochemistry 41 (10-11), 875-880, 2008 | 145 | 2008 |
| Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma RF Gerlach, C Demacq, K Jung, JE Tanus-Santos Clinical biochemistry 40 (1-2), 119-123, 2007 | 143 | 2007 |
| Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities RF Gerlach, JA Uzuelli, CD Souza-Tarla, JE Tanus-Santos Analytical biochemistry 344 (1), 147-149, 2005 | 137 | 2005 |
| Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling MM Castro, E Rizzi, CM Prado, MA Rossi, JE Tanus-Santos, RF Gerlach Matrix Biology 29 (3), 194-201, 2010 | 134 | 2010 |
| Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities CD Souza-Tarla, JA Uzuelli, AA Machado, RF Gerlach, JE Tanus-Santos Clinical biochemistry 38 (5), 410-414, 2005 | 134 | 2005 |
| Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy AM Marcaccini, AB Novaes Jr, CA Meschiari, SL Souza, DB Palioto, ... Clinica chimica acta 409 (1-2), 117-122, 2009 | 129 | 2009 |
| Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome FM Gonçalves, ALB Jacob-Ferreira, VA Gomes, A Casella-Filho, ... Clinica Chimica Acta 403 (1-2), 173-177, 2009 | 126 | 2009 |
| Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental … FRS Gutierrez, MM Lalu, FS Mariano, CM Milanezi, C Jonathan, ... The Journal of infectious diseases 197 (10), 1468-1476, 2008 | 117 | 2008 |
| Circulating matrix metalloproteinases and their inhibitors in hypertension V Fontana, PS Silva, RF Gerlach, JE Tanus-Santos Clinica Chimica Acta 413 (7-8), 656-662, 2012 | 114 | 2012 |
| Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension MM Castro, JE Tanus-Santos, RF Gerlach Pharmacological research 64 (6), 567-572, 2011 | 111 | 2011 |
| Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase‐2 activity and expression in a model of renovascular hypertension CS Ceron, MM Castro, E Rizzi, MF Montenegro, V Fontana, MCO Salgado, ... British journal of pharmacology 160 (1), 77-87, 2010 | 111 | 2010 |
